Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Samsung BioLogics
Samsung BioLogics
CDMO Samsung Biologics bags $1.2B production contract, bringing total 2024 deal value to $3.3B+
Fierce Pharma
Wed, 10/23/24 - 11:20 am
Samsung BioLogics
CDMOs
South Korea
Samsung Bio Nabs $1B Manufacturing Contract With Undisclosed US Pharma
BioSpace
Tue, 07/2/24 - 11:23 am
Samsung BioLogics
drug manufacturing
FDA approves two biosimilars to blockbuster eye drug Eylea
Reuters
Mon, 05/20/24 - 11:23 am
Regeneron
Eylea
FDA
biosimilars
Biocon Biologics
Yesafli
Opuviz
Samsung BioLogics
Biogen
With record year, Samsung Biologics bucks CDMO industry's troublesome 2023
Fierce Pharma
Thu, 01/25/24 - 11:24 am
Samsung BioLogics
drug manufacturing
CDMOs
Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement
Fierce Pharma
Mon, 09/18/23 - 12:30 pm
Samsung BioLogics
Bristol Myers Squibb
drug manufacturing
antibodies
Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M
BioSpace
Wed, 07/5/23 - 11:44 am
Pfizer
Samsung BioLogics
drug manufacturing
biosimilars
Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing
Pharmaceutical Business Review
Thu, 06/8/23 - 09:45 am
Samsung BioLogics
Pfizer
biosimilars
Samsung Biologics spells out expansion plans in South Korea and US
Endpoints
Mon, 01/30/23 - 10:25 am
Samsung BioLogics
South Korea
CDMOs
Samsung Biologics on track to open ‘super plant’ in October
Biopharma Reporter
Thu, 07/28/22 - 05:56 pm
Samsung BioLogics
drug manufacturing
Super Plant
Samsung Biologics signs 426 bln-won land purchase deal to build 2nd campus
Yonhap News Agency
Mon, 07/18/22 - 07:17 pm
Samsung BioLogics
South Korea
CDMOs
Amidst large investment from parent company, Samsung Biologics seeks to ramp up biotech funding
Endpoints
Thu, 06/16/22 - 10:42 pm
Samsung BioLogics
funding
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
Fierce Pharma
Sat, 01/22/22 - 02:14 pm
GSK
Vir Biotechnology
COVID-19
antibodies
drug manufacturing
Samsung BioLogics
To buy or not to buy? Samsung unit denies report about Biogen talks
Fierce Pharma
Thu, 12/30/21 - 11:09 am
Biogen
Samsung BioLogics
M&A
Samsung Biologics to help Enzolytics advance clinical development of mAbs
Biopharma Reporter
Mon, 10/11/21 - 10:13 am
Samsung BioLogics
Enzolytics
CDMOs
monoclonal antibodies
Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more
Fierce Pharma
Tue, 08/24/21 - 11:07 am
Samsung BioLogics
CDMOs
hirings
drug manufacturing
Samsung Biologics to provide end-to-end mRNA vaccine manufacturing
Biopharma Reporter
Mon, 05/31/21 - 07:06 pm
Samsung BioLogics
MRNA
vaccines
COVID-19
South Korea
drug manufacturing
Moderna taps Samsung for fill-finish duties on 'hundreds of millions' of COVID-19 vaccine doses
Fierce Pharma
Mon, 05/24/21 - 11:22 pm
Moderna Therapeutics
Samsung BioLogics
vaccines
COVID-19
Samsung BioLogics says decision pending on making Moderna vaccine as report ignites share
Yahoo/Reuters
Fri, 05/14/21 - 10:52 am
Samsung BioLogics
Moderna Therapeutics
COVID-19
vaccines
South Korea
contract drug manufacturing
Samsung Biologics and TG Therapeutics expand blood cancer partnership
Biopharma Reporter
Tue, 04/27/21 - 10:53 am
TG Therapeutics
Samsung BioLogics
ublituximab
monoclonal antibodies
Samsung eyes manufacturing expansions into U.S. and beyond as work on Korean 'Super Plant' plows ahead
Fierce Pharma
Tue, 01/19/21 - 09:24 pm
Samsung BioLogics
South Korea
drug manufacturing
Super Plant
Pages
1
2
next ›
last »